MediBloc

MediBloc

Trading
21,506 Views
MediBloc’s healthcare information platform is a personal data ecosystem for patients, providers and researchers, built on blockchain technology. Our mission is to streamline medicine for patients, providers and researchers by redistributing value behind personal healthcare data ownership.Through MediBloc, you can effectively own your medical data, providers can remove redundancies to provide better care, and your valuable data can help researchers push the advancement of medicine faster than ever.
General
Website: Visit
White paper: Read
ICO Time: 13 Nov 2017 - 26 Nov 2017
Country: Gibraltar
Token info
Ticker: MED
Platform: QRC
Available for sale: 5,000,000,000 MED (50%)
Total supply: 8,338,650,256.0000 MED
Financial
Raised $ 30,000,000
ICO Price: ≈ 0.0088 USD
Accepting: QTUM, ETH, BTC
Screenshots taken on 5 Feb 2018
October 2017
MediBloc whitepaper release MediBloc POC
November 2017
Crowdfunding
May 2018
MediBlock SDK
June 2018
Mediblock Platform Alpha +HL7 CDA, DICOM support
October 2018
MediBlock platform beta & data network
December 2018
MediBlock platform full version
Dr. Allen Wookyun Kho
Co-Founder Business Development
Participates in a number of projects
Chaeho Shin
Director of Business Development
Participates in a number of projects
Saehan Park
Full Stack Developer
Participates in a number of projects
Hyunkyung Bae
Project Manager
Participates in a number of projects
Bokyung Min
Marketing Director
Participates in a number of projects
Grace Choi China
Market Director
Participates in a number of projects
Minji Kim
Community Manager
Participates in a number of projects

Advisors (10)

Sang Min Park
Advisor, MD in Seoul National Univ. Hospital
No participating data
Hyun Wook Han
Advisor, MD in Ajou Univ. Hospital
No participating data
Simon Seojoon Kim
Advisor, Board Member
Participates in a number of projects
Yiseul Cho
Advisor
Participates in a number of projects
Mai Fujimoto
Advisor, Blockchain Evangelist in Japan
No participating data
KJ Eee
Advisor, ICON Foundation Council
No participating data
Jeong Ho Seok
Legal Advisor
Participates in a number of projects
Alex Shin
Marketing Advisor
Participates in a number of projects
Minkyoo Cha
Advisor
Participates in a number of projects
Dr. Eunsol Lee
Co-Founder System Architect
Participates in a number of projects
ICO List
Other Interesting ICOs
Upcoming
Universal Recognition Token
Universal Recognition Token is the first blockchain-based corporate rewards marketplace where employees may sell and auction their gifts, rewards and prizes to the general public. URT is disrupting a $90 billion dollar annual spend market in the United States alone, according to the Incentive Federation.
Upcoming
Talao
Talao is the first Ethereum-based DAO for Talent, which introduces a unique way for users to own their data thanks to a secure digital vault storing their certificates on the blockchain. Talao provides a decentralized marketplace, governed by Talent, on which neither intermediaries nor commissions apply.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
Xsure
Xsure is a decentralized risk management platform that facilitates real-time communication between insurance providers and the end customer. With the help of machine learning and blockchain trust-less governance technologies we have managed to eliminate third parties from the whole insurance life-cycle and turn it into a dynamic process instead of a static one.
Active
KardiaChain
KardiaChain is the blockchain of blockchains. A scalable and interoperable blockchain platform for decentralized applications. Our Vision: We believe Blockchain can create equal opportunities for people, a world where people have access to opportunity to invest, to start a business, to work and to be socially mobile. Our technology empowers mass adoption, expand use-cases and lay foundation of the blockchain ecosystem. We are building a blockchain platform for decentralised applications helping to create a blockchain ecosystem that allows for scaling and connecting disparate blockchains. Our Core Technology is: - Dual Node - Elastic Sharding With Incentive Mechanism (ESWIM) - Kardia Smart Contract Markup Language (KSML) Our Use cases are: - Supply Chain Management - Fully Decentralised Cross-chain Exchange - Smart City
Upcoming
LOHN
Lohn is a widely spread contractual form in various industrial fields of international cooperation relations, especially in the industry of clothing, footwear, leather, furniture, software and hardware, pharmaceutical, metal working, metallurgical, machine tools, automotive, automation, machine building industry, electronics and appliance industry, food and beverage industry, petrochemical industry. The lohn (processing economy) has been and will be a solution to produce goods at reasonable and high-quality prices through the efficient use of labor and cheap raw materials in emerging economies. It is also a business model that creates economic and social progress across the world bringing together markets with productive resources and capabilities. The trading platform developed by the lohncontrol project will create global opportunities for small and medium-sized businesses that are responsible for generating 60% of GDP. It will give them a visibility that they do not have at this time and will encourage the development of direct business between them. This means low manufacturing costs and greater adaptation to market demands. Those who will win at the end of this interaction will be consumers who will get good products at realistic prices.